<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">110495</id>
  <title nil="true"/>
  <common-name>C.I. Direct Blue 78, tetrasodium salt</common-name>
  <description>C.I. Direct Blue 78, tetrasodium salt belongs to the 1,1'-azonaphthalenes, a subclass of naphthalenes within the organic compounds. It has the formula C42H25N7Na4O13S4 and is classified as a benzenoid. With an average molecular weight of 1,056 g/mol, C.I. Direct Blue 78, tetrasodium salt is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id nil="true"/>
  <chemical-formula>C42H25N7Na4O13S4</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-05T18:59:31Z</created-at>
  <updated-at type="dateTime">2026-04-05T18:59:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[Na+].[Na+].[Na+].[Na+].OC1=C(N=NC2=CC=C(N=NC3=CC=C(N=NC4=CC(=CC=C4S([O-])(=O)=O)S([O-])(=O)=O)C4=C3C=C(C=C4)S([O-])(=O)=O)C3=C2C=CC=C3)C2=CC(NC3=CC=CC=C3)=CC=C2C=C1S([O-])(=O)=O</moldb-smiles>
  <moldb-formula>C42H25N7Na4O13S4</moldb-formula>
  <moldb-inchi>InChI=1S/C42H29N7O13S4.4Na/c50-42-40(66(60,61)62)20-24-10-11-26(43-25-6-2-1-3-7-25)21-32(24)41(42)49-47-35-16-15-34(29-8-4-5-9-30(29)35)44-46-37-18-17-36(31-14-12-27(22-33(31)37)63(51,52)53)45-48-38-23-28(64(54,55)56)13-19-39(38)65(57,58)59;;;;/h1-23,43,50H,(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62);;;;/q;4*+1/p-4</moldb-inchi>
  <moldb-inchikey>MIJVKZQQSWANSK-UHFFFAOYSA-J</moldb-inchikey>
  <moldb-average-mass type="decimal">1055.9</moldb-average-mass>
  <moldb-mono-mass type="decimal">1054.998395</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM106388</chemdb-id>
  <dsstox-id>DTXSID0041725</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00081714</susdat-id>
  <iupac>Tetrasodium 2-{[4-({4-[(7-anilino-2-hydroxy-3-sulfonatonaphthalen-1-yl)diazenyl]naphthalen-1-yl}diazenyl)-6-sulfonatonaphthalen-1-yl]diazenyl}benzene-1,4-disulfonate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Naphthalenes</klass>
  <subklass>1,1'-azonaphthalenes</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0146862</sync-id>
  <structure-inchikey>MIJVKZQQSWANSK-UHFFFAOYSA-J</structure-inchikey>
  <structure-fingerprint>2000000000000000000000000002800800000000000100300000000000000010000200000001004000020000000004800000000000000000000080100000000000000000000000000000002000108020000000000001001004000000000000000000010000100810000000100000000000201000000400000000000000000000000008000000800000000000000080000000040100040000000000000000000000040000000000040000080000000000000000000000080021000000080000000000040200002000000000000002400000000000010004000200000000200000000000000801000040000000000000000000000400000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABGAAAASQAAAIABCyAKAAAAAQELIAoAAAAB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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:43:30Z</structure-indexed-at>
</compound>
